• Case-Based Roundtable
  • General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis
  • Buy-and-Bill

Article

Dendritic cells found in atopic dermatitis skin

Researchers now trying to determine how to deactivate newly discovered cells

Related Videos
Related Content
Insights From the ADORING 3 Study and Tapinarof’s Treatment-Free Periods in AD
March 8th 2025

Insights From the ADORING 3 Study and Tapinarof’s Treatment-Free Periods in AD

The Cutaneous Connection: Combatting Treatment Skepticism in Advanced Pediatric Atopic Dermatitis
August 1st 2023

The Cutaneous Connection: Combatting Treatment Skepticism in Advanced Pediatric Atopic Dermatitis

FDA Accepts Supplemental New Drug Application for Arcutis’ Roflumilast in Children with AD
February 26th 2025

FDA Accepts Supplemental New Drug Application for Arcutis’ Roflumilast in Children with AD

The Cutaneous Connection
August 5th 2021

The Cutaneous Connection: Episode 28- The Path to Understanding Pediatric Melanoma

Study Finds Propranolol Initiation for Infantile Hemangiomas Safe with Less Monitoring
February 25th 2025

Study Finds Propranolol Initiation for Infantile Hemangiomas Safe with Less Monitoring

Phase 3 Trial Supports Roflumilast for Pediatric AD
February 24th 2025

Phase 3 Trial Supports Roflumilast for Pediatric AD

© 2025 MJH Life Sciences

All rights reserved.